What kind of antibodies are strong against the new coronavirus? "Science" latest research finds key factors

The development of an effective vaccine is an extremely urgent task in order to halt the worldwide pandemic of the new coronavirusrecovering from the new coronavirus, many researchers have identified neutralizing antibodies made by the body's immune systembased on this, scientists are designing and developing vaccinesA team of researchers led by the Scripps Research Institute analyzed nearly 300 human-source neutralizing antibodies and found that antibodies that are particularly powerful in the medium and new crown virushave have key in common in molecular characteristics: related to the same antibody-coding gene, according to a new study published today in the leading academic journal Scienceresearchers point out that determining the antibodies encoded by the gene is a key factor in the immune response, meaning that the levels of such antibodies may provide an indirect marker for the ongoing and upcoming clinical trials of the new coronavaccines"This is important for designing an efficient COVID-19 vaccinestudy co-author Professor Dennis Burton saidteam first analyzed 294 different neutralizing antibodiesthese antibodies have been isolated from the blood of patients in the new coronary period of rehabilitation over the past few months, and can target the S protein on the surface of the new coronavirus to block the virus's binding to host cellsantibodies inhumans are made from immune cell B cells, each of which encodes a specific class of antibodies based on a unique combination of antibody genes within the cellin the study, the scientists found that the IGHV3-53 antibody gene, which encodes the heavy chain variable region (a component of the antibody), is the most commonly used gene among these neutralizing antibodies, about 10 percent;next, using high-resolution X-ray crystallography, the team analyzed the details of antibodies in the expression fragments of two IGHV3-53 genes, further revealing the structural characteristics of these antibodies effectively binding to the new coronavirus targetsresearchers also noted that the IGHV3-53 encoded antibody fragments found in the study had only a small variation compared to a small number of original versions of the blood circulation of healthy peoplethis means that increasing the number of such antibodies with vaccines is an achievable goalthis is because, in general, B cells encounter the virus and begin to multiply at the same time, part of the antibody gene mutates in order to produce new B cells, producing antibodies more suitable for the target of the virusin this "affinity maturation" process, the more mutations needed to produce viruses and antibodies, meaning that it is more difficult to induce the process with a vaccine fortunate, "these IGHV3-53-encoded antibodies for the new coronavirus require an efficient neutralizing antibody response to the target without requiring affinity to mature," the study authors concluded therefore, the vaccine may be relatively easy to induce a protective response from these powerful neutralizing antibodies " coronavirus has been around us for hundreds of years, and it is conceivable that our immune system is evolving and the body carries an immediate and powerful response Professor Ian Wilson, one of the lead authors of the study, said ()